{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:53:57Z","timestamp":1771671237349,"version":"3.50.1"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2011,8,9]],"date-time":"2011-08-09T00:00:00Z","timestamp":1312848000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1038\/nrneph.2011.96","type":"journal-article","created":{"date-parts":[[2011,8,9]],"date-time":"2011-08-09T10:02:02Z","timestamp":1312884122000},"page":"517-526","source":"Crossref","is-referenced-by-count":47,"title":["Management of hepatorenal syndrome in patients with cirrhosis"],"prefix":"10.1038","volume":"7","author":[{"given":"Vicente","family":"Arroyo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,9]]},"reference":[{"key":"BFnrneph201196_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0002-9343(70)80073-0","volume":"49","author":"M Epstein","year":"1970","unstructured":"Epstein, M. et al. Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am. J. Med. 49, 175\u2013185 (1970).","journal-title":"Am. J. Med."},{"key":"BFnrneph201196_CR2","first-page":"1175","volume":"89","author":"M Epstein","year":"1977","unstructured":"Epstein, M., Schneider, N. & Befeler, B. Relationship of systemic and intrarenal hemodynamics in cirrhosis. J. Lab. Clin. Med. 89, 1175\u20131187 (1977).","journal-title":"J. Lab. Clin. Med."},{"key":"BFnrneph201196_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/00365518609086479","volume":"46","author":"JH Henriksen","year":"1986","unstructured":"Henriksen, J. H., Ring-Larsen, H. & Christensen, N. J. Catecholamines in plasma from artery, cubital vein, and femoral vein in patients with cirrhosis. Significance of sampling site. Scand. J. Clin. Lab. Invest. 46, 39\u201344 (1986).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"BFnrneph201196_CR4","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/hep.1840160510","volume":"16","author":"JH Henriksen","year":"1992","unstructured":"Henriksen, J. H. et al. Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, beta-adrenergic blockade and atrial natriuretic factor. Hepatology 16, 1163\u20131170 (1992).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1055\/s-2008-1040323","volume":"28","author":"V Arroyo","year":"2008","unstructured":"Arroyo, V., Fernandez, J. & Gin\u00e8s, P. Pathogenesis and treatment of hepatorenal syndrome. Semin. Liver Dis. 28, 81\u201395 (2008).","journal-title":"Semin. Liver Dis."},{"issue":"Suppl. 1","key":"BFnrneph201196_CR6","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/S0168-8278(03)00007-2","volume":"38","author":"V Arroyo","year":"2003","unstructured":"Arroyo, V. & Colmenero, J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J. Hepatol. 38 (Suppl. 1), S69\u2013S89 (2003).","journal-title":"J. Hepatol."},{"key":"BFnrneph201196_CR7","first-page":"788","volume":"17","author":"A Maroto","year":"1993","unstructured":"Maroto, A. et al. Brachial and femoral artery blood flow in cirrhosis: relationship to kidney dysfunction. Hepatology 17, 788\u2013793 (1993).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR8","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/0016-5085(95)90214-7","volume":"108","author":"D Sacerdoti","year":"1995","unstructured":"Sacerdoti, D. et al. Hepatic arterial resistance in cirrhosis with and without portal vein thrombosis: relationships with portal hemodynamics. Gastroenterology 108, 1152\u20131158 (1995).","journal-title":"Gastroenterology"},{"key":"BFnrneph201196_CR9","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1053\/j.gastro.2008.10.057","volume":"136","author":"P Iversen","year":"2009","unstructured":"Iversen, P. et al. Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathy. Gastroenterology 136, 863\u2013871 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrneph201196_CR10","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","volume":"38","author":"L Ruiz-del-Arbol","year":"2003","unstructured":"Ruiz-del-Arbol, L. et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 38, 1210\u20131218 (2003).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/hep.20766","volume":"42","author":"L Ruiz-del-Arbol","year":"2005","unstructured":"Ruiz-del-Arbol, L. et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 42, 439\u2013447 (2005).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1136\/gut.2009.180570","volume":"59","author":"A Krag","year":"2010","unstructured":"Krag, A., Bendtsen, F., Henriksen, J. H. & M\u00f8ller, S. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut 59, 105\u2013110 (2010).","journal-title":"Gut"},{"key":"BFnrneph201196_CR13","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/S0140-6736(56)90149-0","volume":"271","author":"R Hecker","year":"1956","unstructured":"Hecker, R. & Sherlock, S. Electrolyte and circulatory changes in terminal liver failure. Lancet 271, 1121\u20131125 (1956).","journal-title":"Lancet"},{"key":"BFnrneph201196_CR14","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1056\/NEJM196906192802501","volume":"280","author":"MH Koppel","year":"1969","unstructured":"Koppel, M. H. et al. Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functional nature of renal failure in advanced liver disease. N. Engl. J. Med. 280, 1367\u20131371 (1969).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201196_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/hep.510270107","volume":"27","author":"M Guevara","year":"1998","unstructured":"Guevara, M. et al. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology 27, 35\u201341 (1998).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0168-8278(98)80151-7","volume":"29","author":"A Hadengue","year":"1998","unstructured":"Hadengue, A. et al. Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J. Hepatol. 29, 565\u2013570 (1998).","journal-title":"J. Hepatol."},{"key":"BFnrneph201196_CR17","first-page":"268","volume":"61","author":"O Le Moine","year":"1998","unstructured":"Le Moine, O. et al. Treatment with terlipressin as a bridge to liver transplantation in a patient with hepatorenal syndrome. Acta Gastroenterol. Belg. 61, 268\u2013270 (1998).","journal-title":"Acta Gastroenterol. Belg."},{"key":"BFnrneph201196_CR18","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/hep.510290629","volume":"29","author":"P Angeli","year":"1999","unstructured":"Angeli, P. et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 29, 1690\u20131697 (1999).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR19","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/hep.510300430","volume":"30","author":"V G\u00fclberg","year":"1999","unstructured":"G\u00fclberg, V., Bilzer, M. & Gerbes, A. L. Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine. Hepatology 30, 870\u2013875 (1999).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","volume":"33","author":"J Uriz","year":"2000","unstructured":"Uriz, J. et al. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J. Hepatol. 33, 43\u201348 (2000).","journal-title":"J. Hepatol."},{"key":"BFnrneph201196_CR21","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/00042737-200212000-00013","volume":"14","author":"C Alessandria","year":"2002","unstructured":"Alessandria, C. et al. Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2. Eur. J. Gastroenterol. Hepatol. 14, 1363\u20131368 (2002).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrneph201196_CR22","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1053\/jhep.2002.34343","volume":"36","author":"C Duvoux","year":"2002","unstructured":"Duvoux, C. et al. Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study. Hepatology 36, 374\u2013380 (2002).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/00042737-200202000-00009","volume":"14","author":"C Halimi","year":"2002","unstructured":"Halimi, C. et al. Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study. Eur. J. Gastroenterol. Hepatol. 14, 153\u2013158 (2002).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrneph201196_CR24","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1053\/gast.2002.32364","volume":"122","author":"R Moreau","year":"2002","unstructured":"Moreau, R. et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology 122, 923\u2013930 (2002).","journal-title":"Gastroenterology"},{"key":"BFnrneph201196_CR25","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1053\/jhep.2002.35819","volume":"36","author":"R Ortega","year":"2002","unstructured":"Ortega, R. et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology 36, 941\u2013948 (2002).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","volume":"47","author":"C Alessandria","year":"2007","unstructured":"Alessandria, C. et al. Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study. J. Hepatol. 47, 499\u2013505 (2007).","journal-title":"J. Hepatol."},{"key":"BFnrneph201196_CR27","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s10620-007-9919-9","volume":"53","author":"S Neri","year":"2008","unstructured":"Neri, S. et al. Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome. Dig. Dis. Sci. 53, 830\u2013835 (2008).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrneph201196_CR28","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","volume":"134","author":"M Mart\u00edn-Llah\u00ed","year":"2008","unstructured":"Mart\u00edn-Llah\u00ed, M. et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology 134, 1352\u20131359 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrneph201196_CR29","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","volume":"134","author":"AJ Sanyal","year":"2008","unstructured":"Sanyal, A. J. et al. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 134, 1360\u20131368 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrneph201196_CR30","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/00007890-199102000-00030","volume":"51","author":"TA Gonwa","year":"1991","unstructured":"Gonwa, T. A., Morris, C. A., Goldstein, R. M., Husberg, B. S. & Klintmalm, G. B. Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome\u2014experience in 300 patients. Transplantation 51, 428\u2013430 (1991).","journal-title":"Transplantation"},{"key":"BFnrneph201196_CR31","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1111\/j.1600-6143.2006.01526.x","volume":"6","author":"TA Gonwa","year":"2006","unstructured":"Gonwa, T. A. et al. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am. J. Transplant. 6, 2651\u20132659 (2006).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201196_CR32","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1053\/jhep.2002.33160","volume":"35","author":"S Nair","year":"2002","unstructured":"Nair, S., Verma, S. & Thuluvath, P. J. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 35, 1179\u20131185 (2002).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jhep.2003.09.019","volume":"40","author":"T Restuccia","year":"2004","unstructured":"Restuccia, T. et al. Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case\u2013control study. J. Hepatol. 40, 140\u2013146 (2004).","journal-title":"J. Hepatol."},{"key":"BFnrneph201196_CR34","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.jhep.2007.02.001","volume":"46","author":"V Arroyo","year":"2007","unstructured":"Arroyo, V., Terra, C. & Gin\u00e8s, P. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome. J. Hepatol. 46, 935\u2013946 (2007).","journal-title":"J. Hepatol."},{"key":"BFnrneph201196_CR35","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J. Hepatol. 53, 397\u2013417 (2010).","DOI":"10.1016\/j.jhep.2010.05.004"},{"key":"BFnrneph201196_CR36","first-page":"1310","volume":"56","author":"F Salerno","year":"2007","unstructured":"Salerno, F., Gerbes, A., Gin\u00e8s, P., Wong, F. & Arroyo, V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56, 1310\u20131318 (2007).","journal-title":"Gut"},{"key":"BFnrneph201196_CR37","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/hep.510230122","volume":"23","author":"V Arroyo","year":"1996","unstructured":"Arroyo, V. et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 23, 164\u2013176 (1996).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR38","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/hep.1840200619","volume":"20","author":"A Follo","year":"1994","unstructured":"Follo, A. et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 20, 1495\u20131501 (1994).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/hep.1840170215","volume":"17","author":"C Toledo","year":"1993","unstructured":"Toledo, C. et al. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 17, 251\u2013257 (1993).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR40","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1053\/j.gastro.2005.09.024","volume":"129","author":"C Terra","year":"2005","unstructured":"Terra, C. et al. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterology 129, 1944\u20131953 (2005).","journal-title":"Gastroenterology"},{"key":"BFnrneph201196_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/hep.21443","volume":"45","author":"S Fasolato","year":"2007","unstructured":"Fasolato, S. et al. Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology 45, 223\u2013229 (2007).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR42","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1365-2249.2007.03494.x","volume":"150","author":"R Franc\u00e9s","year":"2007","unstructured":"Franc\u00e9s, R. et al. Translocation of bacterial DNA from Gram-positive microorganisms is associated with a species-specific inflammatory response in serum and ascitic fluid of patients with cirrhosis. Clin. Exp. Immunol. 150, 230\u2013237 (2007).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrneph201196_CR43","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s10875-007-9090-2","volume":"27","author":"R Franc\u00e9s","year":"2007","unstructured":"Franc\u00e9s, R. et al. Bacterial DNA induces the complement system activation in serum and ascitic fluid from patients with advanced cirrhosis. J. Clin. Immunol. 27, 438\u2013444 (2007).","journal-title":"J. Clin. Immunol."},{"key":"BFnrneph201196_CR44","first-page":"1500","volume":"54","author":"J Such","year":"2005","unstructured":"Such, J., Mu\u00f1oz, C., Zapater, P. & P\u00e9rez-Mateo, M. Bacterial DNA induces a proinflammatory immune response in patients with decompensated cirrhosis. Gut 54, 1500 (2005).","journal-title":"Gut"},{"key":"BFnrneph201196_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1053\/jhep.2002.33715","volume":"36","author":"J Such","year":"2002","unstructured":"Such, J. et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites. Hepatology 36, 135\u2013141 (2002).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0016-5085(79)90268-3","volume":"77","author":"TD Boyer","year":"1979","unstructured":"Boyer, T. D., Zia, P. & Reynolds, T. B. Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease. Gastroenterology 77, 215\u2013222 (1979).","journal-title":"Gastroenterology"},{"key":"BFnrneph201196_CR47","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1210\/jcem-48-6-895","volume":"48","author":"RD Zipser","year":"1979","unstructured":"Zipser, R. D., Hoefs, J. C., Speckart, P. F., Zia, P. K. & Horton, R. Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease. J. Clin. Endocrinol. Metab. 48, 895\u2013900 (1979).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneph201196_CR48","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1042\/cs0630555","volume":"63","author":"M Epstein","year":"1982","unstructured":"Epstein, M., Lifschitz, M., Ramachandran, M. & Rappaport, K. Characterization of renal prostaglandin E responsiveness in decompensated cirrhosis: implications for renal sodium handling. Clin. Sci. (Lond.) 63, 555\u2013563 (1982).","journal-title":"Clin. Sci. (Lond.)"},{"key":"BFnrneph201196_CR49","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0016-5085(83)90133-6","volume":"84","author":"RD Zipser","year":"1983","unstructured":"Zipser, R. D., Radvan, G. H., Kronborg, I. J., Duke, R. & Little, T. E. Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors. Gastroenterology 84, 697\u2013703 (1983).","journal-title":"Gastroenterology"},{"key":"BFnrneph201196_CR50","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/ki.1984.136","volume":"26","author":"RM P\u00e9rez-Ayuso","year":"1984","unstructured":"P\u00e9rez-Ayuso, R. M. et al. Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis. Kidney Int. 26, 72\u201380 (1984).","journal-title":"Kidney Int."},{"key":"BFnrneph201196_CR51","first-page":"530","volume":"17","author":"G Laffi","year":"1997","unstructured":"Laffi, G., La Villa, G., Pinzani, M., Marra, F. & Gentilini, P. Arachidonic acid derivatives and renal function in liver cirrhosis. Semin. Nephrol. 17, 530\u2013548 (1997).","journal-title":"Semin. Nephrol."},{"key":"BFnrneph201196_CR52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0016-5085(82)90129-9","volume":"82","author":"J Cabrera","year":"1982","unstructured":"Cabrera, J. et al. Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage. Gastroenterology 82, 97\u2013105 (1982).","journal-title":"Gastroenterology"},{"key":"BFnrneph201196_CR53","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1002\/hep.22605","volume":"48","author":"G Garcia-Tsao","year":"2008","unstructured":"Garcia-Tsao, G., Parikh, C. R. & Viola, A. Acute kidney injury in cirrhosis. Hepatology 48, 2064\u20132077 (2008).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR54","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/hep.20373","volume":"40","author":"M Guevara","year":"2004","unstructured":"Guevara, M. et al. Effects of contrast media on renal function in patients with cirrhosis: a prospective study. Hepatology 40, 646\u2013651 (2004).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR55","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1053\/jhep.2001.27830","volume":"34","author":"A C\u00e1rdenas","year":"2001","unstructured":"C\u00e1rdenas, A. et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology 34, 671\u2013676 (2001).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR56","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/0016-5085(87)91007-9","volume":"93","author":"P Gin\u00e9s","year":"1987","unstructured":"Gin\u00e9s, P. et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology 93, 234\u2013241 (1987).","journal-title":"Gastroenterology"},{"key":"BFnrneph201196_CR57","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J. Hepatol. 53, 397\u2013417 (2010).","DOI":"10.1016\/j.jhep.2010.05.004"},{"key":"BFnrneph201196_CR58","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1053\/jhep.2003.50315","volume":"38","author":"KP Moore","year":"2003","unstructured":"Moore, K. P. et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 38, 258\u2013266 (2003).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR59","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1056\/NEJM197006182822502","volume":"282","author":"L Shear","year":"1970","unstructured":"Shear, L., Ching, S. & Gabuzda, G. J. Compartmentalization of ascites and edema in patients with hepatic cirrhosis. N. Engl. J. Med. 282, 1391\u20131396 (1970).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201196_CR60","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/BF02777753","volume":"27","author":"S Sugano","year":"1992","unstructured":"Sugano, S. Endotoxin levels in cirrhotic rats with sterile and infected ascites. Gastroenterol. Jpn 27, 348\u2013353 (1992).","journal-title":"Gastroenterol. Jpn"},{"key":"BFnrneph201196_CR61","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0168-8278(00)80272-X","volume":"33","author":"J Heller","year":"2000","unstructured":"Heller, J. et al. Effects of lipopolysaccharide on TNF-\u03b1lpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis. J. Hepatol. 33, 376\u2013381 (2000).","journal-title":"J. Hepatol."},{"key":"BFnrneph201196_CR62","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/hep.510270507","volume":"27","author":"M Navasa","year":"1998","unstructured":"Navasa, M. et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 27, 1227\u20131232 (1998).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR63","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM199908053410603","volume":"341","author":"P Sort","year":"1999","unstructured":"Sort, P. et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N. Engl. J. Med. 341, 403\u2013409 (1999).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201196_CR64","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0272-6386(12)80451-3","volume":"19","author":"DH Crawford","year":"1992","unstructured":"Crawford, D. H. et al. Universal occurrence of glomerular abnormalities in patients receiving liver transplants. Am. J. Kidney Dis. 19, 339\u2013344 (1992).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201196_CR65","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/00313029500169053","volume":"27","author":"RA Axelsen","year":"1995","unstructured":"Axelsen, R. A. et al. Renal glomerular lesions in unselected patients with cirrhosis undergoing orthotopic liver transplantation. Pathology 27, 237\u2013246 (1995).","journal-title":"Pathology"},{"key":"BFnrneph201196_CR66","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1478-3231.2009.02182.x","volume":"30","author":"JM Trawal\u00e9","year":"2010","unstructured":"Trawal\u00e9, J. M. et al. The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study. Liver Int. 30, 725\u2013732 (2010).","journal-title":"Liver Int."},{"key":"BFnrneph201196_CR67","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1159\/000319505","volume":"33","author":"J Malyszko","year":"2010","unstructured":"Malyszko, J. Biomarkers of acute kidney injury in different clinical settings: a time to change the paradigm? Kidney Blood Press. Res. 33, 368\u2013382 (2010).","journal-title":"Kidney Blood Press. Res."},{"key":"BFnrneph201196_CR68","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1007\/s10620-010-1377-0","volume":"55","author":"A Duseja","year":"2010","unstructured":"Duseja, A. et al. Non-hepatic insults are common acute precipitants in patients with acute on chronic liver failure (ACLF). Dig. Dis. Sci. 55, 3188\u20133192 (2010).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrneph201196_CR69","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.transproceed.2010.03.095","volume":"42","author":"G Novelli","year":"2010","unstructured":"Novelli, G. et al. Predictive parameters after molecular absorbent recirculating system treatment integrated with model for end stage liver disease model in patients with acute-on-chronic liver failure. Transplant. Proc. 42, 1182\u20131187 (2010).","journal-title":"Transplant. Proc."},{"key":"BFnrneph201196_CR70","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jhep.2004.10.019","volume":"42","author":"HE Wasmuth","year":"2005","unstructured":"Wasmuth, H. E. et al. Patients with acute on chronic liver failure display \u201csepsis-like\u201d immune paralysis. J. Hepatol. 42, 195\u2013201 (2005).","journal-title":"J. Hepatol."},{"key":"BFnrneph201196_CR71","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2249.2006.03259.x","volume":"147","author":"T Xing","year":"2007","unstructured":"Xing, T., Li, L., Cao, H. & Huang, J. Altered immune function of monocytes in different stages of patients with acute on chronic liver failure. Clin. Exp. Immunol. 147, 184\u2013188 (2007).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrneph201196_CR72","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.gastrohep.2009.10.003","volume":"33","author":"A Escorsell Ma\u00f1osa","year":"2010","unstructured":"Escorsell Ma\u00f1osa, A. & Mas Ordeig, A. Acute on chronic liver failure [Spanish]. Gastroenterol. Hepatol. 33, 126\u2013134 (2010).","journal-title":"Gastroenterol. Hepatol."},{"key":"BFnrneph201196_CR73","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/hep.1840020303","volume":"2","author":"H Ring-Larsen","year":"1982","unstructured":"Ring-Larsen, H., Hesse, B., Henriksen, J. H. & Christensen, N. J. Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis: plasma norepinephrine concentration, hepatic extraction, and renal release. Hepatology 2, 304\u2013310 (1982).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR74","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3109\/00365517709100657","volume":"37","author":"H Ring-Larsen","year":"1977","unstructured":"Ring-Larsen, H. Renal blood flow in cirrhosis: relation to systemic and portal haemodynamics and liver function. Scand. J. Clin. Lab. Invest. 37, 635\u2013642 (1977).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"BFnrneph201196_CR75","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep.1840080532","volume":"8","author":"RW Schrier","year":"1988","unstructured":"Schrier, R. W. et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8, 1151\u20131157 (1988).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR76","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.gastrohep.2009.06.010","volume":"33","author":"V Reichenbach","year":"2010","unstructured":"Reichenbach, V., Ros, J. & Jim\u00e9nez, W. Endogenous cannabinoids in liver disease: many darts for a single target [Spanish]. Gastroenterol. Hepatol. 33, 323\u2013329 (2010).","journal-title":"Gastroenterol. Hepatol."},{"key":"BFnrneph201196_CR77","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1023\/A:1026618904493","volume":"44","author":"J Genesca","year":"1999","unstructured":"Genesca, J. et al. Adrenomedullin, a vasodilator peptide implicated in hemodynamic alterations of liver cirrhosis: relationship to nitric oxide. Dig. Dis. Sci. 44, 372\u2013376 (1999).","journal-title":"Dig. Dis. Sci."},{"issue":"2 Suppl. 1","key":"BFnrneph201196_CR78","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1002\/hep.20993","volume":"43","author":"Y Iwakiri","year":"2006","unstructured":"Iwakiri, Y. & Groszmann, R. J. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 43 (2 Suppl. 1), S121\u2013S131 (2006).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR79","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/0016-5085(93)90655-V","volume":"104","author":"CC Sieber","year":"1993","unstructured":"Sieber, C. C., Lopez-Talavera, J. C. & Groszmann, R. J. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 104, 1750\u20131754 (1993).","journal-title":"Gastroenterology"},{"key":"BFnrneph201196_CR80","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/hep.1840060315","volume":"6","author":"E Sikuler","year":"1986","unstructured":"Sikuler, E. & Groszmann, R. J. Hemodynamic studies in long- and short-term portal hypertensive rats: the relation to systemic glucagon levels. Hepatology 6, 414\u2013418 (1986).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR81","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1053\/jhep.2003.50304","volume":"38","author":"D De las Heras","year":"2003","unstructured":"De las Heras, D. et al. Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis. Hepatology 38, 452\u2013459 (2003).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR82","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/0002-9343(86)90912-5","volume":"81","author":"V Arroyo","year":"1986","unstructured":"Arroyo, V., Gin\u00e9s, P., Rimola, A. & Gaya, J. Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis. Am. J. Med. 81, 104\u2013122 (1986).","journal-title":"Am. J. Med."},{"key":"BFnrneph201196_CR83","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/S0002-9440(10)64331-3","volume":"162","author":"G Fern\u00e1ndez-Varo","year":"2003","unstructured":"Fern\u00e1ndez-Varo, G. et al. Nitric oxide synthase 3-dependent vascular remodeling and circulatory dysfunction in cirrhosis. Am. J. Pathol. 162, 1985\u20131993 (2003).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph201196_CR84","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/0016-5085(91)90222-7","volume":"100","author":"J Claria","year":"1991","unstructured":"Claria, J. et al. Effect of V1-vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascites. Gastroenterology 100, 494\u2013501 (1991).","journal-title":"Gastroenterology"},{"key":"BFnrneph201196_CR85","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0168-8278(87)80542-1","volume":"4","author":"G Daskalopoulos","year":"1987","unstructured":"Daskalopoulos, G., Pinzani, M., Murray, N., Hirschberg, R. & Zipser, R. D. Effects of captopril on renal function in patients with cirrhosis and ascites. J. Hepatol. 4, 330\u2013336 (1987).","journal-title":"J. Hepatol."},{"key":"BFnrneph201196_CR86","doi-asserted-by":"publisher","first-page":"G726","DOI":"10.1152\/ajpgi.00162.2009","volume":"297","author":"J Colmenero","year":"2009","unstructured":"Colmenero, J. et al. Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C. Am. J. Physiol. Gastrointest. Liver Physiol. 297, G726\u2013G734 (2009).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrneph201196_CR87","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","volume":"94","author":"P Gin\u00e8s","year":"1988","unstructured":"Gin\u00e8s, P. et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 94, 1493\u20131502 (1988).","journal-title":"Gastroenterology"},{"key":"BFnrneph201196_CR88","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","volume":"111","author":"A Gin\u00e8s","year":"1996","unstructured":"Gin\u00e8s, A. et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 111, 1002\u20131010 (1996).","journal-title":"Gastroenterology"},{"key":"BFnrneph201196_CR89","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/hep.22853","volume":"49","author":"BA Runyon","year":"2009","unstructured":"Runyon, B. A. & AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatology 49, 2087\u20132107 (2009).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR90","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1046\/j.1440-1746.2002.02816.x","volume":"17","author":"I Colle","year":"2002","unstructured":"Colle, I. et al. Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis. J. Gastroenterol. Hepatol. 17, 882\u2013888 (2002).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrneph201196_CR91","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","volume":"18","author":"P Solanki","year":"2003","unstructured":"Solanki, P. et al. Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J. Gastroenterol. Hepatol. 18, 152\u2013156 (2003).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrneph201196_CR92","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/hep.23286","volume":"51","author":"LL Gluud","year":"2010","unstructured":"Gluud, L. L., Christensen, K., Christensen, E. & Krag, A. Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome. Hepatology 51, 576\u2013584 (2010).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR93","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/hep.23283","volume":"51","author":"A Nazar","year":"2010","unstructured":"Nazar, A. et al. Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 51, 219\u2013226 (2010).","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"BFnrneph201196_CR94","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/S0168-8278(09)60177-X","volume":"50","author":"P Angeli","year":"2009","unstructured":"Angeli, P. et al. Terlipressin given as continuous intravenous infusion versus terlipressin given as intravenous boluses in the treatment of type 1 hepatorenal syndrome (HRS) in patients with cirrhosis [abstract 175]. J. Hepatol. 50 (Suppl. 1), S73 (2009).","journal-title":"J. Hepatol."},{"key":"BFnrneph201196_CR95","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","volume":"103","author":"P Sharma","year":"2008","unstructured":"Sharma, P., Kumar, A., Shrama, B. C. & Sarin, S. K. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response. Am. J. Gastroenterol. 103, 1689\u20131697 (2008).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrneph201196_CR96","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/hep.20262","volume":"40","author":"F Wong","year":"2004","unstructured":"Wong, F., Pantea, L. & Sniderman, K. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 40, 55\u201364 (2004).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR97","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s10620-006-9312-0","volume":"52","author":"E Esrailian","year":"2007","unstructured":"Esrailian, E., Pantangco, E. R., Kyulo, N. L., Hu, K. Q. & Runyon, B. A. Octreotide\/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Dig. Dis. Sci. 52, 742\u2013748 (2007).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrneph201196_CR98","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/MCG.0b013e318188947c","volume":"43","author":"C Skagen","year":"2009","unstructured":"Skagen, C., Einstein, M., Lucey, M. R. & Said, A. Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome. J. Clin. Gastroenterol. 43, 680\u2013685 (2009).","journal-title":"J. Clin. Gastroenterol."},{"key":"BFnrneph201196_CR99","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/hep.510280219","volume":"28","author":"M Guevara","year":"1998","unstructured":"Guevara, M. et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 28, 416\u2013422 (1998).","journal-title":"Hepatology"},{"key":"BFnrneph201196_CR100","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1136\/gut.47.2.288","volume":"47","author":"KA Brensing","year":"2000","unstructured":"Brensing, K. A. et al. Long-term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 47, 288\u2013295 (2000).","journal-title":"Gut"},{"key":"BFnrneph201196_CR101","first-page":"1753","volume":"50","author":"G Testino","year":"2003","unstructured":"Testino, G. et al. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Hepatogastroenterology 50, 1753\u20131755 (2003).","journal-title":"Hepatogastroenterology"},{"key":"BFnrneph201196_CR102","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/08860229509026250","volume":"17","author":"F Keller","year":"1995","unstructured":"Keller, F. et al. Risk factors and outcome of 107 patients with decompensated liver disease and acute renal failure (including 26 patients with hepatorenal syndrome): the role of hemodialysis. Ren. Fail. 17, 135\u2013146 (1995).","journal-title":"Ren. Fail."},{"key":"BFnrneph201196_CR103","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1081\/JDI-200035988","volume":"26","author":"RK Capling","year":"2004","unstructured":"Capling, R. K. & Bastani, B. The clinical course of patients with type 1 hepatorenal syndrome maintained on hemodialysis. Ren. Fail. 26, 563\u2013568 (2004).","journal-title":"Ren. Fail."},{"key":"BFnrneph201196_CR104","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1002\/hep.21930","volume":"46","author":"TI Hassanein","year":"2007","unstructured":"Hassanein, T. I. et al. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 46, 1853\u20131862 (2007).","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"BFnrneph201196_CR105","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S0168-8278(10)60008-6","volume":"52","author":"K Rifai","year":"2010","unstructured":"Rifai, K. et al. Extracorporeal liver support by fractionated plasma separation and adsorption (Prometheus) in patients with acute-on-chronic liver failure (Helios study): a prospective randomized controlled multicenter study [abstract 6]. J. Hepatol. 52 (Suppl. 1), S3 (2010).","journal-title":"J. Hepatol."},{"issue":"Suppl. 1","key":"BFnrneph201196_CR106","doi-asserted-by":"publisher","first-page":"S459","DOI":"10.1016\/S0168-8278(10)61185-3","volume":"52","author":"R Ba\u00f1ares","year":"2010","unstructured":"Ba\u00f1ares, R. et al. Extracorporeal liver support with the molecular adsorbent recirculating system (MARS) in patients with acute-on-chronic liver failure (AOCLF). The RELIEF trial [abstract 1184]. J. Hepatol. 52 (Suppl. 1), S459\u2013S460 (2010).","journal-title":"J. Hepatol."},{"issue":"Suppl. 5","key":"BFnrneph201196_CR107","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1046\/j.1365-2036.16.s5.3.x","volume":"16","author":"JH Henriksen","year":"2002","unstructured":"Henriksen, J. H., Kiszka-Kanowitz, M. & Bendtsen, F. Review article: volume expansion in patients with cirrhosis. Aliment. Pharmacol. Ther. 16 (Suppl. 5), 12\u201323 (2002).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrneph201196_CR108","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","volume":"133","author":"J Fern\u00e1ndez","year":"2007","unstructured":"Fern\u00e1ndez, J. et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 133, 818\u2013824 (2007).","journal-title":"Gastroenterology"},{"key":"BFnrneph201196_CR109","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jhep.2008.01.024","volume":"48","author":"R Terg","year":"2008","unstructured":"Terg, R. et al. Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study. J. Hepatol. 48, 774\u2013779 (2008).","journal-title":"J. Hepatol."},{"key":"BFnrneph201196_CR110","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1053\/gast.2000.20189","volume":"119","author":"E Akriviadis","year":"2000","unstructured":"Akriviadis, E. et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 119, 1637\u20131648 (2000).","journal-title":"Gastroenterology"}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2011.96.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2011.96","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2011.96.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T16:46:35Z","timestamp":1686242795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2011.96"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,9]]},"references-count":110,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["BFnrneph201196"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2011.96","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,9]]}}}